Effects of dietary caffeine on mood when rested and sleep restricted

Human Psychopharmacology
Jack E James, M Elizabeth Douglas Gregg

Abstract

Prolonged use of caffeine can lead to physical dependence evidenced by characteristic withdrawal symptoms during abstinence. Debate exists as to whether mood enhancement by caffeine represents a net effect or merely the restoration of abstinence-induced mood decrements. One aim of this study was to determine the net effects on mood of dietary caffeine compared with prolonged abstinence. In addition, the study aimed to determine whether caffeine restores mood degraded by a non-caffeine source, namely, sleep restriction. A double-blind placebo-controlled cross-over design was employed in which 48 male and female volunteers alternated weekly between ingesting placebo and caffeine (1.75 mg/kg) three times daily for 4 consecutive weeks, while being either rested or sleep restricted. Mood was assessed using a computerized version of the profile of mood states (POMS), giving scores for overall mood and six mood dimensions. Gender had small effects on mood, whereas all mood dimensions were markedly adversely affected by sleep restriction. Caffeine had no significant net enhancing effects on mood when participants were rested, and produced no net restorative effects when mood was degraded by sleep restriction. On the contrary, caffeine-...Continue Reading

References

Jul 1, 1978·Clinical Pharmacology and Therapeutics·W D Parsons, A H Neims
Jan 1, 1992·Journal of the Experimental Analysis of Behavior·K Silverman, R R Griffiths
Jan 1, 1991·European Journal of Clinical Pharmacology·C P DenaroN L Benowitz
Apr 1, 1989·British Journal of Clinical Pharmacology·J E JamesN R Scott
Jan 1, 1987·Psychopharmacology·H R LiebermanI L Coviella
Apr 1, 1988·Journal of Clinical Pharmacy and Therapeutics·H N AlkaysiY M el-Sayed
Mar 1, 1986·Journal of the Experimental Analysis of Behavior·R R GriffithsN Russ
Jan 1, 1985·European Journal of Clinical Pharmacology·D R Abernethy, E L Todd
Apr 1, 1981·The Journal of Clinical Investigation·D RobertsonJ A Oates
Jan 1, 1995·Neuropsychobiology·J E James
May 1, 1995·Psychopharmacology·D M Warburton
Jul 1, 1994·Physiology & Behavior·M H Bonnet, D L Arand
Oct 1, 1995·British Journal of Clinical Pharmacology·O AzconaF Jané
Oct 1, 1995·Pharmacology, Biochemistry, and Behavior·N J RichardsonR J O'Dell
May 1, 1996·Psychophysiology·J A Horne, L A Reyner
Dec 24, 1997·Physiology & Behavior·B G Phillips-Bute, J D Lane
Nov 12, 1998·Physiology & Behavior·J D Lane, B G Phillips-Bute
Apr 20, 2001·Amino Acids·J A Horne, L A Reyner
Jan 1, 1994·International Journal of Behavioral Medicine·J E James

❮ Previous
Next ❯

Citations

Dec 17, 2014·Fiziologiia cheloveka·I N Pigarev, M L Pigareva
Aug 20, 2008·Annals of General Psychiatry·Amy J Morgan, Anthony F Jorm
Jan 23, 2014·Experimental Brain Research·Gaétane DeliensPhilippe Peigneux
Jun 4, 2014·Pharmacology, Biochemistry, and Behavior·Jack E James
Jul 24, 2014·Journal of Caffeine Research·Cecile A MarczinskiClifford J Brown
Dec 26, 2015·Regulatory Toxicology and Pharmacology : RTP·Duncan TurnbullGregory F Mariano
Apr 7, 2010·Sleep Medicine Reviews·Marie Vandekerckhove, Raymond Cluydts
Feb 2, 2010·Brain Research Bulletin·Daniela TempestaMichele Ferrara
Mar 21, 2007·Sleep Medicine·Ellen T Kahn-GreeneWilliam D S Killgore
Feb 24, 2006·Journal of Sleep Research·William D S KillgoreNancy J Wesensten
Feb 24, 2006·Journal of Sleep Research·Julie M GottseligHans-Peter Landolt
Nov 5, 2008·Human Psychopharmacology·Michael A Keane, Jack E James
May 28, 2009·Addiction·Venla S LaitalaKarri Silventoinen
Sep 8, 2011·Psychophysiology·M VandekerckhoveR Cluydts
Dec 12, 2013·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Barbara WilhelmHelmut Wilhelm
Mar 19, 2013·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Éanna D O'LearyJack E James
Dec 5, 2014·Nutrition Research Reviews·Richard HammersleyStephen L Atkin
Jan 4, 2017·Canadian Journal of Physiology and Pharmacology·Grace E GilesRobin B Kanarek
Sep 18, 2007·Human Psychopharmacology·Jack E James, Michael A Keane
Aug 2, 2019·Journal of Basic and Clinical Physiology and Pharmacology·Rohit M SaneSanjana N Subhedar
Oct 5, 2017·Canadian Journal of Physiology and Pharmacology·Grace E GilesRobin B Kanarek
Dec 1, 2017·AIMS Neuroscience·Marie Vandekerckhove, Yu-Lin Wang
Jul 6, 2020·Current Nutrition Reports·Welayah A AlAmmarRabie Y Khattab
Apr 26, 2017·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Daniele WikoffCandace Doepker
Sep 21, 2021·PloS One·Alleluia Lima Losno LedesmaFayez Bahmad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.